Diane C. Young - Net Worth and Insider Trading
Diane C. Young Net Worth
The estimated net worth of Diane C. Young is at least $78,858 dollars as of 2024-06-24. Diane C. Young is the SVP, CHIEF MEDICAL OFFICER of Celldex Therapeutics Inc and owns about 2,115 shares of Celldex Therapeutics Inc (CLDX) stock worth over $76,225. Diane C. Young is also the VP, Chief Medical Officer of Oncternal Therapeutics Inc and owns about 328 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $2,634. Details can be seen in Diane C. Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Diane C. Young has not made any transactions after 2024-06-07 and currently still holds the listed stock(s).
Transaction Summary of Diane C. Young
Diane C. Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Diane C. Young owns 2 companies in total, including Celldex Therapeutics Inc (CLDX) , and Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Diane C. Young’s form 4 insider trades.
Insider Ownership Summary of Diane C. Young
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CLDX | Celldex Therapeutics Inc | 2024-06-07 | SVP & Chief Medical Officer |
ONCT | Oncternal Therapeutics Inc | 2018-07-16 | VP & Chief Medical Officer |
Diane C. Young Latest Holdings Summary
Diane C. Young currently owns a total of 2 stocks. Among these stocks, Diane C. Young owns 2,115 shares of Celldex Therapeutics Inc (CLDX) as of June 7, 2024, with a value of $76,225 and a weighting of 96.66%. Diane C. Young also owns 328 shares of Oncternal Therapeutics Inc (ONCT) as of July 16, 2018, with a value of $2,634 and a weighting of 3.34%.
Latest Holdings of Diane C. Young
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CLDX | Celldex Therapeutics Inc | 2024-06-07 | 2,115 | 36.04 | 76,225 |
ONCT | Oncternal Therapeutics Inc | 2018-07-16 | 328 | 8.03 | 2,634 |
Holding Weightings of Diane C. Young
Diane C. Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Diane C. Young has made a total of 4 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 45,000 shares on June 7, 2024, which brought Diane C. Young around $2 Million.
According to the SEC Form 4 filings, Diane C. Young has made a total of 0 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years. The most-recent trade in Oncternal Therapeutics Inc is the sale of 15 shares on July 16, 2018, which brought Diane C. Young around $30,120.
Insider Trading History of Diane C. Young
- 1
Diane C. Young Trading Performance
GuruFocus tracks the stock performance after each of Diane C. Young's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Diane C. Young is 37.18%. GuruFocus also compares Diane C. Young's trading performance to market benchmark return within the same time period. The performance of stocks bought by Diane C. Young within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Diane C. Young's insider trading performs compared to the benchmark.
Performance of Diane C. Young
Diane C. Young Ownership Network
Ownership Network List of Diane C. Young
Ownership Network Relation of Diane C. Young
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Diane C. Young Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Diane C. Young is the SVP & Chief Medical Officer of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP & Chief Product Dev Officer Elizabeth Crowley , SVP and CFO Samuel Bates Martin , and SVP & General Counsel Freddy A. Jimenez .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Diane C. Young made 1 insider transaction in Celldex Therapeutics Inc (CLDX) with a net sale of 45,000. Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 353,560 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 353,560 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,560 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Diane C. Young Mailing Address
Above is the net worth, insider trading, and ownership report for Diane C. Young. You might contact Diane C. Young via mailing address: 175 Toyota Plaza, 7th Floor, Memphis Tn 38103.